OraSure CEO Appointed to Presidential Advisory Council on HIV/AIDS


Doug Michels with PACHA Chairperson Dr. Helene Gayle, M.D., M.P.H., President and Chief Executive Officer, CARE-USA; Atlanta, GA

BETHLEHEM, Pa. – February 3, 2010 – Douglas A. Michels, President and Chief Executive Officer of OraSure Technologies, Inc. (NASDAQ:OSUR), a market leader in oral fluid diagnostics, was sworn in yesterday by U.S. Health and Human Services Secretary Kathleen Sebelius, as a new member of the Presidential Advisory Council on HIV/AIDS (PACHA). You can watch the video of the swearing in ceremony and PACHA's initial meeting here.

[Individuals and organizations around the world react to Michels appointment]

Video: The Presidential Advisory Council on HIV/AIDS (PACHA) is sworn in and holds its initial meeting.
Watch the video

PACHA provides advice, information, and recommendations to the President of the United States through the Secretary of Health and Human Services on domestic and global HIV/AIDS policy issues.

"I'm pleased to have a new group of experts joining PACHA; and I look forward to hearing from the council about our continued efforts to prevent the spread of HIV infections in the United States and to provide care and treatment to people living with HIV/AIDS around the world," said President Obama in a statement issued by the Department of Health and Human Services.

Mr. Michels is one of the 24 new appointees to the Council which is composed of a diverse group of researchers, service providers, and community leaders from around the country.

"I am extremely honored to serve as member of the President's Advisory Council," said Mr. Michels. "I personally have dedicated my career to advances in the healthcare industry, particularly in the areas of HIV, Hepatitis and Drugs of Abuse. I look forward to being a productive contributor to the Council's discussions and deliberations."

In addition to providing advice and recommendations to the President and the Secretary of Health and Human Services, PACHA also serves to further the policy goals of the White House Office of National AIDS Policy (ONAP) and will play an important role in providing input for the National HIV/AIDS Strategy.

"I have had the pleasure to work alongside Doug Michels and his team at OraSure on several critical initiatives and have seen firsthand Doug's personal and professional dedication to fighting the HIV/AIDS epidemic," said John Tedstrom, President and CEO of the Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria. "Mr. Michels exemplifies the type of global executive that inspires others to work harder in our efforts to make the world a healthier place. He will be an extremely valuable member of the Council."


Doug Michels (center) during swearing in ceremony. Michels is flanked by fellow PACHA members Mario Perez, Director of the Office of AIDS Policy and Programs for Los Angeles County (left) and Douglas Brooks, Vice President, Justice Resource Institute.

Since 2004, Mr. Michels has been a driving force behind OraSure Technologies' commitment to working in partnership with local, state, federal and international agencies along with community-based organizations and associations to increase access to HIV prevention education and testing.

"As a former Ambassador to the United Nations and Mayor of one of America's great cities, I understand and recognize the devastating impact that HIV/AIDS is having on our communities both here and abroad.  Understanding the complexities of this epidemic and to have the passion and knowledge to work collaboratively to fight this disease is critical and Mr. Doug Michels is perfectly suited to take on that challenge as a member of the Presidential Advisory Council on HIV/AIDS. I commend President Obama and Secretary Sebelius on his appointment," said the Honorable Andrew Young, Co-Chairman, Goodworks International, former Ambassador to the United Nations and Mayor of Atlanta.

About OraSure Technologies
OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid testing solutions for drugs of abuse and for the detection of antibodies to HIV.

For more information on the Company, please go to www.orasure.com.